Parallax Volatility Advisers
RARX

Parallax Volatility Advisers’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Parallax Volatility Advisers’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,200
Closed -$72K – 4159
2019
Q1 		$72K Hold
3,200
– – ﹤0.01% 2193
2018
Q4 		$58K Buy
+3,200
New +$50.2K ﹤0.01% 2079
2018
Q1 		– Sell
-1,806
Closed -$15K – 4997
2017
Q4 		$15K Buy
+1,806
New +$22.2K ﹤0.01% 3746

Other funds holding RARX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Parallax Volatility Advisers's RARX Position: Q2 2019 in Review

Parallax Volatility Advisers sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2019, closing a stake of 3,200 shares — an estimated $72K sold.

Parallax Volatility Advisers first reported a position in RARX in Q4 2017 and held it in 3 quarters. The position peaked at $72K in Q1 2019. 118 funds tracked by Wall St. Rank hold RARX as of Q2 2019.

  • Parallax Volatility Advisers reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 3,200 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2019, an estimated $72K.
  • Parallax Volatility Advisers first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 3 quarters.
  • Parallax Volatility Advisers's Ra Pharmaceuticals, Inc. Common Stock position peaked at $72K in Q1 2019.
  • 118 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2019.

Based on Parallax Volatility Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.